Skip to search formSkip to main contentSkip to account menu

Januvia

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

sitagliptinsitagliptin phosphate
sitagliptin 100 MG Oral Tablet [Januvia]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
PHARMACEUTICAL QUALITY OF GENERIC SITAGLIPTIN TABLETS COMPARED WITH JANUVIA
Sitagliptin is relatively new hypoglycemic agent. Several generic products are available in the Middle East. However, their… 
2013
2013
A novel data-mining platform leveraging social media to monitor outcomes of Januvia
A novel data-mining method was developed to gauge the experiences of the diabetes mellitus drug Januvia. Self-organizing maps… 
2008
2008
[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].
Sitagliptin (Januvia) is the first selective antagonist of dipeptidylpeptidase-4, an enzyme that degrades glucagon-like peptide-1… 
2008
2008
Selective Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type 2 Diabetes: The Discovery of JANUVIA(™) (Sitagliptin)
2007
2007
Sitagliptin (Januvia) for type 2 diabetes.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)